featured
Cost Advantage of Optical Diagnosis With a "Resect and Discard" Strategy Within the English Bowel Cancer Screening Program
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastrointestinal Endoscopy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Economic impact of implementing optical diagnosis with a "resect and discard" strategy within the English Bowel Cancer Screening Programme: Findings from the DISCARD3 study
Gastrointest. Endosc. 2023 Feb 03;[EPub Ahead of Print], M Orlovic, A Ahmad, BP SaundersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.